Congrats to DrMBartonBurke, Director of Nursing Research at MSK for winning the Oncology Nursing Society 2024 Lifetime Achievement Award! 👏👏👏

This Administrative Professionals Day, I’d like to acknowledge our extraordinary colleagues for their countless contributions in support of MSK’s mission.

🏥 How can nurses help patients understand a HER2+ breast cancer diagnosis?

🗨️ Experts from Memorial Sloan Kettering Cancer Center, New York Oncology Hematology, Lifespan Health System, & Florida Cancer Specialists share their insights in part 1 of this new roundtable series.

📺 Watch now: buff.ly/3UVIwYP

#bcsm

Happy administrative professionals day!! Everyday, the amazing admin staff Memorial Sloan Kettering Cancer Center help me care for patients with precision & grace. Thank your admins today (& every day)! They make a difference.

Fun fact: Today my office coordinator brought in home made pickles! 🥒 🥰

We continue to fund innovative #lungcancer research, including this project by Alvaro Quintanal-Villalonga of Memorial Sloan Kettering Cancer Center which hopes to understand why most lung tumors become resistant to treatments. Learn more at: on.lung.org/3UDlWUJ

Now that Cycle for Survival has wrapped up another season of impact and inspiration, we want to thank you for making this community so amazing. Let's revisit some of our favorite memories from the 2024 season! #CycleforSurvival

One week to go! Don't miss out on the excitement at this year's #MSKlymphomaCME Memorial Sloan Kettering Cancer Center. Dive into cutting-edge topics, engage w/ top experts, network w/ peers; plus, an exclusive session tailored for nurses & APPs. Register: bit.ly/Lymphoma2024

Gilles Salles

The TSOG, run by MSK & AATS is meeting the need for more #thoracic surgical #oncology trials. “With 4 new trials planned to open in 2024, the future of thoracic surgical clinical trials looks bright indeed,” says thoracic cancer surgeon Jones David R.. bit.ly/3vWaLfV

☢️Memorial Sloan Kettering Cancer Center skin cancer expert Dr Christopher A. Barker weighs in on a IJROBP - The Red Journal #GrayZone case of a patient with a cT4aN0M0 cutaneous squamous cell carcinoma of the bilateral parietal scalp, which is possibly recurrent after prior treatment.
sciencedirect.com/science/articl…

Great discussion at the end of the first session of #iwCART 24 with Justus Weber (Universitätsklinikum Würzburg), Smita Chandran (@MSKCancerCenter) and David Maloney (@fredhutch) 🌟

#iwCART #CARTcell #CellTherapy

.Alex Edelman, Tina Fey, Jim Gaffigan, nick kroll, Last Week Tonight, & more will perform at Comedy vs Cancer at Jazz at Lincoln Center on 5/7. Every ticket purchase supports lifesaving #bloodcancer research at MSK. More: bit.ly/3SWivG4

(The lineup is subject to change.)

What are the risk factors and treatment options for essential thrombocythemia?

The latest Blood Cancer Talks episode with Raajit Rampal, M.D.Ph.D., of Memorial Sloan Kettering Cancer Center, provides insight!

🎧 Listen here: buff.ly/4aVcMro

Ashwin Kishtagari, MD Eddie Cliff Raj Chakraborty

🚨 Hot off the press 🚨

How does chimeric antigen receptor T cell therapy shape the risk of subsequent malignant neoplasm?

Check out our new publication from #shouvallab Memorial Sloan Kettering Cancer Center out today in JAMA Oncology ⤵️

jamanetwork.com/journals/jamao…

Not to be missed! Join us on April 29-30 for the 2024 Developmental Oncology Symposium Memorial Sloan Kettering Cancer Center. Network w/ renowned experts & explore cutting-edge updates on pediatric & young adult cancers. Secure your spot: bit.ly/DevOnc2024

#MSKDevOnc #MSKkids Kentsis Research Group

VIRTUAL SYMPOSIUM | Join Memorial Sloan Kettering Cancer Center on 4/23 for its evidence-based course designed to optimize care of #OlderAdult oncology patients by advancing the knowledge & expertise of advanced practice providers. Hear from keynote speaker Carolyn Clancy MD.

ow.ly/pNcI50RhfT5

#CICON24 isn't just a conference- it's a prime networking opportunity to connect with experts and peers. Register today to attend the Eighth International Cancer Immunotherapy Conference: Translating Science into Survival, held from September 8-11, 2024: bit.ly/49Bceq8

Congratulations to unit M18 at Memorial Sloan Kettering Cancer Center for being the recipient of the DAISY Team Award - Tracy Gosselin

#Cancer #MemorialSloanKettering #Cancer Center #NYPD #OncoDaily #Oncology

oncodaily.com/49531.html

MSK genitourinary oncologist Andy Laccetti MD, MS discusses Masofaniten (EPI-7386), a pioneering anti-androgen therapy that targets the N-terminal domain of the androgen receptor, aimed at overcoming resistance mechanisms observed with current #prostatecancer treatments. Learn more ⬇️

Congratulations Michel Sadelain! He was honored along with Carl June for their development of chimeric antigen receptor T cell immunotherapy, whereby a patient’s T cells are modified to target and kill cancer cells. @academymuseum Breakthrough #breakthrough Memorial Sloan Kettering Cancer Center

💊 Dr. William Jarnagin of Memorial Sloan Kettering Cancer Center describes how his latest study shows the benefits of regional #chemotherapy and hepatic artery infusion chemotherapy for intrahepatic #cholangiocarcinoma .

📺 Watch the full interview: buff.ly/4arPolr

#BileDuctCancer